Clinical Trial

FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control

Study acronym: FIM+DASH
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to treat both hypertension and obesity in adults using a food is medicine framework. Participants will be randomized 1:1 to FIM+DASH or usual-care control. The 24-week trial includes a 12-week FIM+DASH intervention followed by a 12-week maintenance period and leverages existing partnerships with community-based organizations for home food delivery and culinary skill-skill building. The main questions it aims to answer are: (1) What is the effect of FIM+DASH vs. usual care control on blood pressure? (2) What is the effect of FIM+DASH vs. usual care control on DASH diet adherence (diet quality), body weight, and waist circumference? (3) How to identify factors associated with the sustainability and scalability of FIM+DASH in real-world settings?
Protocol Amendment History 4 changes
critical Recruitment opened 2026-07-11
critical Primary endpoint(s) modified 2026-07-11
notable Primary completion pushed: 2029-03 -> 2030-06-30 2026-07-11
minor Completion pushed: 2029-06 -> 2030-09 2026-07-11
Trial Details
NCT Number NCT07332741
Lead Sponsor University of Illinois at Chicago
Conditions Hypertension, Hypertension (HTN), Obesity & Overweight
Enrollment 150 participants
Start Date 2026-05-22
Primary Completion 2030-06-30 (estimated)
Study Completion 2030-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-10